BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16186645)

  • 1. Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia.
    Schouten JA; Prins JM; Bonten MJ; Degener J; Janknegt RE; Hollander JM; Jonkers RE; Wijnands WJ; Verheij TJ; Sachs AP; Kullberg BJ;
    Neth J Med; 2005 Sep; 63(8):323-35. PubMed ID: 16186645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia].
    Schouten JA; Prins JM; Bonten M; Degener JE; Janknegt R; Hollander JM; Jonkers R; Wijnands W; Verheij T; Sachs A; Kullberg BJ
    Ned Tijdschr Geneeskd; 2005 Nov; 149(45):2495-500. PubMed ID: 16304886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two guidelines on community-acquired pneumonia: both an important basis for individual policies].
    van den Broek PJ
    Ned Tijdschr Geneeskd; 2005 Nov; 149(45):2492-4. PubMed ID: 16304885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National guidelines for the use of antibiotics in hospitalised adult patients: the SWAB guidelines revisited.
    Prins JM; Kullberg BJ; Gyssens IC
    Neth J Med; 2005 Sep; 63(8):288-90. PubMed ID: 16186637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Updated acute community-acquired pneumonia in adults: Guidelines for initial antimicrobial therapy based on local evidence from the South American Working Group (ConsenSur II)].
    Bantar C; Curcio D; Jasovich A; Bagnulo H; Arango A; Bavestrello L; Famiglietti A; García P; Lopardo G; Losanovscky M; Martínez E; Pedreira W; Piñeyro L; Remolif C; Rossi F; Varón F
    Rev Chilena Infectol; 2010 Jun; 27 Suppl 1():S9-S38. PubMed ID: 20737129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adults.
    Wiersinga WJ; Bonten MJ; Boersma WG; Jonkers RE; Aleva RM; Kullberg BJ; Schouten JA; Degener JE; Janknegt R; Verheij TJ; Sachs AP; Prins JM; ;
    Neth J Med; 2012 Mar; 70(2):90-101. PubMed ID: 22418758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors.
    Schouten JA; Hulscher ME; Kullberg BJ; Cox A; Gyssens IC; van der Meer JW; Grol RP
    J Antimicrob Chemother; 2005 Sep; 56(3):575-82. PubMed ID: 16049096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Community-acquired pneumonia].
    Blanquer J; Sanz F
    Arch Bronconeumol; 2010 Oct; 46 Suppl 7():26-30. PubMed ID: 21316547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of new therapies for severe community-acquired pneumonia.
    Restrepo MI; Anzueto A
    Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.
    Niven DJ; Laupland KB
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):69-81. PubMed ID: 19622058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New guidelines for the management of adult community-acquired pneumonia.
    Armitage K; Woodhead M
    Curr Opin Infect Dis; 2007 Apr; 20(2):170-6. PubMed ID: 17496576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival.
    Bodí M; Rodríguez A; Solé-Violán J; Gilavert MC; Garnacho J; Blanquer J; Jimenez J; de la Torre MV; Sirvent JM; Almirall J; Doblas A; Badía JR; García F; Mendia A; Jordá R; Bobillo F; Vallés J; Broch MJ; Carrasco N; Herranz MA; Rello J;
    Clin Infect Dis; 2005 Dec; 41(12):1709-16. PubMed ID: 16288392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community acquired bacterial pneumonia.
    Anevlavis S; Bouros D
    Expert Opin Pharmacother; 2010 Feb; 11(3):361-74. PubMed ID: 20085502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The correct approach to community-acquired pneumonia in immunocompetent adults: review of current guidelines.
    Carbonara S; Stano F; Scotto G; Monno L; Angarano G
    New Microbiol; 2008 Jan; 31(1):1-18. PubMed ID: 18437837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Community-acquired pneumonia--treatment perspectives in the physician's office].
    Ewig S
    MMW Fortschr Med; 2004 May; 146(21):43-5. PubMed ID: 15373084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-acquired pneumonia in adults: initial antibiotic therapy.
    King DE; Pippin HJ
    Am Fam Physician; 1997 Aug; 56(2):544-50. PubMed ID: 9262534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting.
    Segreti J; House HR; Siegel RE
    Am J Med; 2005 Jul; 118 Suppl 7A():21S-28S. PubMed ID: 15993674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic testing to establish a microbial cause is helpful in the management of community-acquired pneumonia.
    Skerrett SJ
    Semin Respir Infect; 1997 Dec; 12(4):308-21. PubMed ID: 9436958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of aetiological tests for guiding antibiotic therapy in community-acquired pneumonia.
    Strålin K
    Int J Antimicrob Agents; 2008 Jan; 31(1):3-11. PubMed ID: 17920819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [National consensus for management of community acquired pneumonia in adults].
    Saldías P F; Pérez C C
    Rev Chilena Infectol; 2005; 22 Suppl 1():s7-s10. PubMed ID: 16163422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.